Newsletter Subject

Join the fight: Support diabetes research and save lives

From

diabetes.org

Email Address

donotreply@diabetes.org

Sent On

Tue, Jul 23, 2024 09:03 PM

Email Preheader Text

Your donation fuels critical research that impacts diabetes prevention and care. ???????

Your donation fuels critical research that impacts diabetes prevention and care.                                                      ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏   ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Your donation fuels critical research that impacts diabetes prevention and care. [American Diabetes Association Logo] Research Is Key in the Fight to End Diabetes "As a first timer, I've got to say that the ADA’s Scientific Sessions is impressive. I realized that THIS is the fight. THIS is where the fight will be won. Lives will be changed, and all of us will end diabetes together." -Molly Butz, the ADA’s Web Lifestyle Content Manager and living with T1 diabetes [Donate Now]( Your donation can help advance diabetes research and care! Friend, We’ve officially wrapped up this year’s 84th Scientific Sessions of the American Diabetes Association® (ADA), the world’s largest meeting on diabetes research, prevention, and care. The 84th Scientific Sessions provided a fresh outlook on the lifesaving research that will improve the lives of millions living with diabetes—and so will your donation! The Scientific Sessions unveiled cutting-edge research such as: - Weight-loss drug reduces kidney disease risk by 24% Findings from a new trial showed that semaglutide (a weight-loss medication) significantly reduces the risk of major kidney disease events and cardiovascular causes in people with type 2 diabetes and chronic kidney disease (CKD). - Breakthrough studies on AID and CGM New data revealed that technology such as automated insulin delivery (AID) systems and continuous glucose monitoring (CGM) improve blood glucose (blood sugar) levels and overall diabetes management. - Innovations in medications for people with obesity In addition to helping people with obesity reach a healthy weight, findings from these studies showed that weight-loss medications also improve blood glucose and blood pressure management and reduce cholesterol levels while preserving lean mass (which mostly includes muscle) - Weight-loss drug shown to improve sleep apnea and CVD Findings from a study discovered that people with sleep apnea and obesity who took tirzepatide (a weight-loss medication) significantly improved their sleep apnea, lost weight, and reduced their risk for cardiovascular disease (CVD). This premier gathering of some of the world’s brightest minds and experts on diabetes research and treatment brings groundbreaking innovations from the lab to everyday care. This critical work is pivotal in diabetes prevention and management—and so is your support! [Support Research]( A donation from you today may support lifesaving diabetes treatments, fuels research to reduce severe complications from diabetes, and funds critical research to find a cure. Friend, you can support the fight to end diabetes once and for all alongside ADA researchers to make a difference in the lives of the 136 million Americans living with diabetes or prediabetes with your donation. Will you stand with us in the fight? [Stand with Us]( [Donate Monthly]( [Donate Once]( Ways to Give: [Monthly]( | [Once]( | [Stock]( | [Employer Match]( | [Donate Your Car]( Ways to Give: [Monthly]( | [Once]( | [Stock]( [Employer Match]( | [Donate Your Car]( [Facebook]( [Twitter]( [Instagram]( [Linkedin]( [YouTube]( © American Diabetes Association. All rights reserved. askada@diabetes.org | 1-800-342-2383 Learn more at [diabetes.org]( [Forward to a Friend]( [Manage Your Communication]( | [Unsubscribe](

Marketing emails from diabetes.org

View More
Sent On

04/12/2024

Sent On

03/12/2024

Sent On

05/11/2024

Sent On

22/10/2024

Sent On

22/10/2024

Sent On

18/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.